• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病患者 COVID-19 住院治疗的结果:一项全国性分析。

Outcomes of COVID-19 hospitalizations in patients with sickle cell disease: A nationwide analysis.

机构信息

Department of Internal Medicine, One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, New York, USA.

Department of Internal Medicine, North Mississippi Medical Center, Tupelo, Mississippi, USA.

出版信息

Eur J Haematol. 2023 Sep;111(3):432-440. doi: 10.1111/ejh.14024. Epub 2023 Jun 8.

DOI:10.1111/ejh.14024
PMID:37290934
Abstract

INTRODUCTION

There is a paucity of data on the outcomes of coronavirus disease 2019 (COVID-19) in patients with sickle cell disease (SCD) in the United States. We examined the outcomes of patients with COVID-19 and SCD.

METHODS

We utilized the National Inpatient Sample (NIS) to identify the data of patients diagnosed with COVID-19 and SCD in 2020 using the International Classification of Disease, Tenth Revision codes. In-hospital outcomes (invasive mechanical ventilation and mortality) were compared between SCD and non-SCD groups.

RESULTS

Of the 1 057 550 COVID-19 hospitalizations, 2870 (0.3%) had SCD. The median age of the SCD group was 42 (IQR: 31) vs. 66 (IQR: 23) in the non-SCD group (p < .0001). Patients with SCD were likely to be females (62.02% vs. 37.98%, p < .0001), Blacks (87.81% vs. 12.19%, p < .0001), and in the lowest income quartile (50.62% vs. 11.15%, p < .0001). There was no difference in the outcomes between the two groups. There were increased odds of invasive mechanical ventilation and in-hospital mortality in COVID-19 in Asians, Hispanics, Native Americans, and Blacks (except for in-hospital mortality) compared to Whites.

CONCLUSION

In-hospital mortality and invasive mechanical ventilation outcomes in SCD are comparable to that in non-SCD patients hospitalized with COVID-19.

摘要

简介

在美国,关于冠状病毒病 2019(COVID-19)患者镰状细胞病(SCD)结局的数据很少。我们研究了 COVID-19 和 SCD 患者的结局。

方法

我们利用国家住院患者样本(NIS),使用国际疾病分类,第十次修订版代码,确定 2020 年诊断为 COVID-19 和 SCD 的患者的数据。比较 SCD 和非 SCD 组的住院期间结局(有创机械通气和死亡率)。

结果

在 1057550 例 COVID-19 住院患者中,有 2870 例(0.3%)患有 SCD。SCD 组的中位年龄为 42(IQR:31),而非 SCD 组为 66(IQR:23)(p<0.0001)。SCD 患者更可能为女性(62.02% vs. 37.98%,p<0.0001)、黑人(87.81% vs. 12.19%,p<0.0001)和收入最低的四分位数(50.62% vs. 11.15%,p<0.0001)。两组之间的结局没有差异。与白人相比,亚洲人、西班牙裔、美国原住民和黑人(除了住院死亡率外)的 COVID-19 患者有创机械通气和住院死亡率的可能性更高。

结论

COVID-19 住院的 SCD 患者的住院死亡率和有创机械通气结局与非 SCD 患者相当。

相似文献

1
Outcomes of COVID-19 hospitalizations in patients with sickle cell disease: A nationwide analysis.镰状细胞病患者 COVID-19 住院治疗的结果:一项全国性分析。
Eur J Haematol. 2023 Sep;111(3):432-440. doi: 10.1111/ejh.14024. Epub 2023 Jun 8.
2
Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.美国住院 COVID-19 患者和镰状细胞病患者的血红蛋白基因型的人口统计学和结局。
Eur J Haematol. 2023 Oct;111(4):611-619. doi: 10.1111/ejh.14054. Epub 2023 Jul 21.
3
Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016-2020.2016-2020 年全国住院患者样本中镰状细胞病合并肺栓塞的患病率及结局分析。
Eur J Haematol. 2023 Sep;111(3):441-448. doi: 10.1111/ejh.14025. Epub 2023 Jun 9.
4
Sickle cell disease and coronavirus disease-2019 (COVID-19) infection: a single-center experience.镰状细胞病与 2019 年冠状病毒病(COVID-19)感染:单中心经验。
Postgrad Med J. 2023 Aug 22;99(1175):1008-1012. doi: 10.1093/postmj/qgad033.
5
Sickle cell disease is associated with higher mortality among patients hospitalized with ischemic bowel disease.镰状细胞病与因缺血性肠病住院患者的较高死亡率相关。
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1027-1032. doi: 10.1097/MEG.0000000000001181.
6
Chronic kidney disease and outcomes in hospitalized sickle cell disease patients: A National Inpatient Sample analysis.慢性肾脏病与住院镰状细胞病患者结局的关系:一项全国住院患者样本分析。
Eur J Haematol. 2024 Jul;113(1):24-31. doi: 10.1111/ejh.14201. Epub 2024 Mar 21.
7
Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell disease.住院患者镰状细胞病的住院量、医院教学地位、患者社会经济地位和结局。
Am J Hematol. 2011 Apr;86(4):377-80. doi: 10.1002/ajh.21977.
8
Impact of Depression in Sickle Cell Disease Hospitalization-Related Outcomes: An Analysis of the National Inpatient Sample (NIS).《国家住院患者样本分析:抑郁对镰状细胞病住院相关结局的影响》。
Medicina (Kaunas). 2019 Jul 17;55(7):385. doi: 10.3390/medicina55070385.
9
Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018.2012-2018 年全国住院患者样本中镰状细胞病的严重孕产妇发病率和死亡率。
JAMA Netw Open. 2023 Feb 1;6(2):e2254552. doi: 10.1001/jamanetworkopen.2022.54552.
10
Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions.成人镰状细胞病相关住院治疗的近期全国疗效及经济差异趋势。
Ann Hematol. 2023 Oct;102(10):2659-2669. doi: 10.1007/s00277-023-05388-y. Epub 2023 Jul 31.

引用本文的文献

1
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.红细胞疾病患者中的新型冠状病毒肺炎,来自欧洲登记处ERN-EuroBloodNet的结果
Orphanet J Rare Dis. 2025 Apr 16;20(1):183. doi: 10.1186/s13023-025-03683-7.
2
Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.认识新冠疫情期间原住民的异质性:对加拿大、澳大利亚、新西兰和美国的一项范围综述
BMJ Public Health. 2024 Dec 30;2(2):e001341. doi: 10.1136/bmjph-2024-001341. eCollection 2024 Dec.